Blog

Al-Ola Abdallah: Introduction to U.S. Myeloma Innovations Research Collaborative Group

Al-Ola Abdallah/LinkedIn

Aug 24, 2024, 10:20

Al-Ola Abdallah: Introduction to U.S. Myeloma Innovations Research Collaborative Group

Al-Ola Abdallah, Associate Professor Of Medicine at the University of Kansas Medical Center, shared a post on LinkedIn:

“Evaluating real-world Outcomes, Access Barriers and Scientific Progress: Introduction to U.S. Myeloma Innovations Research Collaborative (USMIRC) Group.

by Daniyal Shahid, Zain Anwar, and Nausheen Ahmed.”

Read further.
Source: Al-Ola Abdallah/LinkedIn

Al-Ola Abdallah cancer Daniyal Shahid Nausheen Ahmed OncoDaily Oncology U.S. Myeloma Innovations Research Collaborative Group University of Kansas Medical Center USMIRC Group Zain Anwar

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage